Advertisement
Advertisement
IXHL
Incannex Healthcare Limited - ADR
3.15
USDSponsored
+0.04
+1.45%
Aug 07, 15:59 UTC -4
Closed
After-Market
3.16
+0.01
+0.16%
IXHL Earnings Reports
Positive Surprise Ratio
IXHL beat 1 of 7 last estimates.
14%
Next Report
Date of Next Report
Sep 28, 2026
Estimate for Q4 26 (Revenue/ EPS)
--
/-$0.76
Implied change from Q3 26 (Revenue/ EPS)
--
/-93.23%
Implied change from Q4 25 (Revenue/ EPS)
--
/-95.03%
Incannex Healthcare Limited - ADR earnings per share and revenue
On May 15, 2026, IXHL reported earnings of -11.22 USD per share (EPS) for Q3 26, missing the estimate of -0.94 USD, resulting in a -1088.38% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +2.06% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 3 analysts forecast an EPS of -0.76 USD, with revenue projected to reach -- USD, implying an decrease of -93.23% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Definium Therapeutics, Inc. Common Shares
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.55
Actual
-$1.44
Surprise
-158.25%
Relay Therapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.39
Actual
-$0.41
Surprise
-2.78%
Amylyx Pharmaceuticals, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.36
Actual
-$0.39
Surprise
-5.95%
Ardelyx, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.05
Actual
-$0.07
Surprise
-18.85%
Collegium Pharmaceutical, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.74
Actual
$1.92
Surprise
+9.75%
Cronos Group Inc. Common Share
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.00
Actual
$0.03
Surprise
0.00%
Relmada Therapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.20
Actual
-$0.11
Surprise
+45.95%
Organogenesis Holdings Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.35
Actual
-$0.71
Surprise
-98.88%
Profound Medical Corp. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.26
Actual
$0.26
Surprise
+199.01%
OmniAb, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.12
Actual
-$0.05
Surprise
+59.15%
FAQ
What were Incannex Healthcare Limited - ADR's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Incannex Healthcare Limited - ADR reported EPS of -$11.22, missing estimates by -1088.38%, and revenue of $0.00, 0% as expectations.
How did the market react to Incannex Healthcare Limited - ADR's Q3 2026 earnings?
The stock price moved up 2.06%, changed from $3.88 before the earnings release to $3.96 the day after.
When is Incannex Healthcare Limited - ADR expected to report next?
The next earning report is scheduled for Sep 28, 2026.
What are the forecasts for Incannex Healthcare Limited - ADR's next earnings report?
Based on 3
analysts, Incannex Healthcare Limited - ADR is expected to report EPS of -$0.76 and revenue of -- for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement